Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Over 42500000 shares.
We need 26% to stop it
Grabbed some weeks ago @ 10p, (unusually for me, the correct move).
The Directors behaviour and performance has been a good lesson going forward.
The selfishness of some people literally has to be seen/experienced first hand to be truly believed.
Best wishes to all.
well done, I had thought of doing the same thing as so undervalued - pleased for you - brave move
I’m just pleased I bought more last week so cut my losses a little but still massive loss.
Disgraceful for the holders who paid loads more . I did say it’s a buy out . The ones who paid 10:s have had a good pay day
Just a lie, pure and simple, to keep the SP down for a sale. Guess enough folk will be happy with the price premium on current sp so it will just slide.
yep, disgraceful - invested in good faith and was in for the long term, lost a packet - directors will come out of it swimmingly.
Has so much going for it
Shafted
Hopefully we’ll get an update on the 7th regarding resubmission and possible funding
Agreed re fundraiser, very clumsy from now departed CEO. Would be interested in your or anyone else’s views on the SMC report and/or insight into how SMC operates.
Yup.
Did you read the detailed report too? Almost a hatchet job, but also seemed like Diurnal were either arrogant or amateurish. Weird, as other experts and countries were much happier.
https://www.scottishmedicines.org.uk/medicines-advice/hydrocortisone-modified-release-hard-capsules-efmody-full-smc2414/?UNLID=3057494742022522152947
Efmody not Alkindi OFC
pretty sure it was Efmody... and it's about time for resubmission.
Love the Eton Pharma news on Alkindi. The Scots doctors didn’t like the Alkindi application as (a) it seemed really poorly presented if you read the details of the rejection, meaning the CEO had to go, and (b) the Scots think that the bl00dy patients should just suck up the existing cheap treatment and stop moaning and backsliding. The fact that it ends up costing the NHS more as patients reject it didn’t seem to matter. Alkindi is much more expensive but is well tolerated and well taken up.
bloody company really need to pull their finger out!
surely it wouldn't be hard to extrapolate from US/Canada... revise the US trials and then talk about the Efmody faux pas...
this share fundraised at 70p in april 2021... poor news outlets aren't helping the recovery. bounced 20% just on pi's commenting. it'd do 15p+ with the right rns...
Most other biotech stocks have had a good bounce and recovery in the last few months (especially in the US).
About time we see that as well. This stock has fallen too far imo.
I think the penny is starting to drop. The only reason I can come up with after the funding needed runs even with millions in the bank, was to suppress the SP for whatever reason. Everything that has happened since doesn't change my mind. Quick to runs some hypothetical future need for funding but silence on some good (though not world changing) sales news.
trying to get Diurnal to post something (frankly, amazed there's no rns but no tweet, either is ridiculous!) as i'd rather the world could see the news rather than a half dozen enthusiasts on these bbs!
Sales of our recently launched ALKINDI SPRINKLE® remain strong, with 293% year-over-year revenue growth, and feedback from the patient and physician communities continues to be overwhelmingly positive.
Continued growth in ALKINDI SPRINKLE®. ALKINDI SPRINKLE sales grew 293% over the second quarter of 2021 and 34% over the first quarter of 2022, demonstrating a strong desire for the low-dose treatment options that ALKINDI SPRINKLE offers.
Just bought some - They will need cash or a licencing deal in the next 6 mths, but I see sales doubling to about £8m over the next 12mths, which should help with any cash raise licencing deal. Sept R&D should give me more details...
man alive but you'd think they'd be at least tweeting something to at least suggest the bigger world wide sales picture, from this news!
https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-reports-second-quarter-2022-financial
They should still own some Eton shares too.